These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 4964203)

  • 1. [Clinical evaluation of the action of dixyrazine on behavioral disorders in children treated in a medico-pedagogic institution].
    d' Hollander L; Fontaine PJ; Stassart-Deryck T
    Acta Neurol Psychiatr Belg; 1967; 67():Suppl:5-35. PubMed ID: 4964203
    [No Abstract]   [Full Text] [Related]  

  • 2. A clinical study of esucos in a mentally retarded clientele.
    Lindholm O
    Acta Neurol Psychiatr Belg; 1967; 67():Suppl:49-64. PubMed ID: 4964202
    [No Abstract]   [Full Text] [Related]  

  • 3. A clinical study of the anxiolytic effect of dixyrazine (Esucos).
    Hakola ML; Hakola P
    Acta Neurol Psychiatr Belg; 1967; 67():Suppl:37-47. PubMed ID: 4964201
    [No Abstract]   [Full Text] [Related]  

  • 4. Sulpiride versus chlorpromazine and placebo in the treatment of restless mentally subnormal patients--a double-blind cross-over study.
    Väisänen K; Kainulainen P; Paavilainen MT; Viukari M
    Curr Ther Res Clin Exp; 1975 Feb; 17(2):202-5. PubMed ID: 803431
    [No Abstract]   [Full Text] [Related]  

  • 5. A clinical study of Esucos in a mentally retarded clientele.
    Lindholm O
    Int J Neuropsychiatry; 1967 Jun; 3(3):209-18. PubMed ID: 5340605
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical studies on a new neuroplegic agent, dixyrazin, in a double blind experiment with the following series of analyses].
    Bensch K; Rundberg B
    Prax Kinderpsychol Kinderpsychiatr; 1965; 14(6):235-9. PubMed ID: 5320652
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical study of a new neuroplegic drug, Dixyrazine, in a double-blind experiment with subsequent serial analysis].
    Bensch K; Rundberg B
    Wien Z Nervenheilkd Grenzgeb; 1965; 22(3):217-24. PubMed ID: 4222763
    [No Abstract]   [Full Text] [Related]  

  • 8. A clinical study of the anxiolytic effect of dixyrazine (Esucos).
    Hakola ML; Hakola P
    Int J Neuropsychiatry; 1967 Jun; 3(3):219-25. PubMed ID: 5340606
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative investigation of the effects of dixyrazine, placebo and chlordiazepoxide on alcoholics during hospital care.
    Malmgren G
    Acta Neurol Psychiatr Belg; 1967; 67():Suppl:65-72. PubMed ID: 4964204
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical comparison of haloperidol with chlorpromazine in mentally retarded children.
    Le Vann LJ
    Am J Ment Defic; 1971 May; 75(6):719-23. PubMed ID: 4932179
    [No Abstract]   [Full Text] [Related]  

  • 11. Propericiazin, diazepam, chlorpromazine and placebo in a doubleblind trial in pedopsychiatric therapy.
    Bartůnková Z; Cerný L; Drtilová J; Sturma J
    Act Nerv Super (Praha); 1972; 14(2):83-4. PubMed ID: 4402693
    [No Abstract]   [Full Text] [Related]  

  • 12. The treatment of behavior disorders in idiocy and imbecility with clozapine.
    Vyncke J
    Pharmakopsychiatr Neuropsychopharmakol; 1974 Sep; 7(5):225-9. PubMed ID: 4614278
    [No Abstract]   [Full Text] [Related]  

  • 13. Hydroxyzine hydrochloride in the management of children with behaviour problems.
    Manchanda SS; Kishore B; Jain CK; Singh G; Kashyap UB
    Indian Pediatr; 1969 Aug; 6(8):538-49. PubMed ID: 4902197
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of thioridazine, amphetamine and placebo on the hyperkinetic syndrome and cognitive area in mentally deficient children.
    Alexandris A; Lundell FW
    Can Med Assoc J; 1968 Jan; 98(2):92-6. PubMed ID: 4864657
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of amitryptyline drops, in ambulatory therapy, on behavior and character disorders in children and adolescents].
    Sallou C
    Rev Neuropsychiatr Infant; 1969 Dec; 17(12):859-64. PubMed ID: 5369060
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of dextroamphetamine, chlorpromazine, and hydroxyzine on behavior and performance in hyperactive children.
    Greenberg LM; Deem MA; McMahon S
    Am J Psychiatry; 1972 Nov; 129(5):532-9. PubMed ID: 4562464
    [No Abstract]   [Full Text] [Related]  

  • 17. Type and prevalence of medication used in the treatment of hyperactive children.
    Krager JM; Safer DJ
    N Engl J Med; 1974 Nov; 291(21):1118-20. PubMed ID: 4417001
    [No Abstract]   [Full Text] [Related]  

  • 18. The psychoactive properties of diphenylhydantoin: experiences with prisoners and juvenile delinquents.
    Resnich O
    Int J Neuropsychiatry; 1967 Dec; 3():Suppl 2:30-6. PubMed ID: 4873471
    [No Abstract]   [Full Text] [Related]  

  • 19. [Masmoran in the treatment of behavior disorders and psychovegetative disorders in children].
    Helpenstein F
    ZFA (Stuttgart); 1976 May; 52(15):811-5. PubMed ID: 779308
    [No Abstract]   [Full Text] [Related]  

  • 20. A STUDY OF IMPROVEMENT IN MENTALLY RETARDED CHILDREN ACCRUING FROM Siccacell therapy.
    Black DB; Kato JG; Walker GW
    Am J Ment Defic; 1966 Jan; 70(4):499-508. PubMed ID: 5325565
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.